Immediate Impact
3 from Science/Nature 69 standout
Citing Papers
Key Issues as Wearable Digital Health Technologies Enter Clinical Care
2024 Standout
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
2023 Standout
Works of P. Rogers being referenced
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
2011
COMPARISON OF OSCILLOMETRIC BLOOD PRESSURE MEASUREMENTS AT THE WRIST WITH AN UPPER‐ARM AUSCULTATORY MERCURY SPHYGMOMANOMETER
1999
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| P. Rogers | 130 | 195 | 129 | 144 | 139 | 16 | 562 | |
| B. Cho | 87 | 63 | 56 | 67 | 110 | 9 | 635 | |
| Fa‐Bao Hao | 66 | 127 | 53 | 90 | 67 | 24 | 638 | |
| Hongbin Shi | 110 | 53 | 69 | 100 | 57 | 21 | 595 | |
| Laura Rosana Aballay | 100 | 211 | 46 | 89 | 66 | 39 | 572 | |
| M Sugiyama | 181 | 95 | 25 | 120 | 154 | 20 | 644 | |
| Yu Tian | 87 | 142 | 53 | 116 | 68 | 34 | 469 | |
| Marinos Pericleous | 87 | 73 | 17 | 176 | 54 | 27 | 601 | |
| Shinji Tabata | 124 | 145 | 69 | 174 | 62 | 22 | 646 | |
| C. Wayne Callaway | 106 | 75 | 48 | 37 | 94 | 20 | 537 | |
| Mitsuhiko Katsurada | 71 | 104 | 26 | 130 | 33 | 18 | 532 |
All Works
Loading papers...